Nishadil
Signup Signin
Delhi | 25°C (windy)
The Pharmaceutical Frontier: How the FDA and White House Are Accelerating Cures and Revolutionizing Drug Prices

The Pharmaceutical Frontier: How the FDA and White House Are Accelerating Cures and Revolutionizing Drug Prices
California's Landmark Initiative: State-Branded Insulin Set to Transform Diabetes Care and Affordability

California's Landmark Initiative: State-Branded Insulin Set to Transform Diabetes Care and Affordability
The High-Stakes Battle Over Elevidys: Efficacy, Ethics, and the Future of Rare Disease Drugs

The High-Stakes Battle Over Elevidys: Efficacy, Ethics, and the Future of Rare Disease Drugs
Europe's Bold New Pharma Gambit: A High-Stakes Bet on Access Over Profit?

Europe's Bold New Pharma Gambit: A High-Stakes Bet on Access Over Profit?
A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review

A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review
Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks

Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks
Crucial Medicare Drug Price Loophole Fix Stalled: A Setback for Patient Savings

Crucial Medicare Drug Price Loophole Fix Stalled: A Setback for Patient Savings
Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals

Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals
The Pharmaceutical Tsunami: How a Second Trump Term Could Reshape Drug Pricing, Medicare, and Vaccines

The Pharmaceutical Tsunami: How a Second Trump Term Could Reshape Drug Pricing, Medicare, and Vaccines
President Trump Unveils Landmark Deals: Slashing Drug Costs and Boosting COVID-19 Testing

President Trump Unveils Landmark Deals: Slashing Drug Costs and Boosting COVID-19 Testing
Trump's Pfizer Deal: A 'Devastating' Blow to PBMs and Insurers, Warns LaMattina

Trump's Pfizer Deal: A 'Devastating' Blow to PBMs and Insurers, Warns LaMattina
A Pharmaceutical Powerhouse Pivots: Pfizer Embraces Trump's 'Most Favored Nation' Pricing

A Pharmaceutical Powerhouse Pivots: Pfizer Embraces Trump's 'Most Favored Nation' Pricing
A Landmark Deal: Pfizer Slashes Drug Costs for Medicaid Patients in Trump Administration Agreement

A Landmark Deal: Pfizer Slashes Drug Costs for Medicaid Patients in Trump Administration Agreement
The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer

The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer
Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs
Trump's Landmark Drug Price Promise: A Deadline Vanished, Unnoticed

Trump's Landmark Drug Price Promise: A Deadline Vanished, Unnoticed
Indian Pharma's Unwavering Allure: Why Mutual Funds Are Doubling Down Amidst Global Headwinds

Indian Pharma's Unwavering Allure: Why Mutual Funds Are Doubling Down Amidst Global Headwinds
America's Pharmaceutical Future: Rekindling the Spark of Innovation

America's Pharmaceutical Future: Rekindling the Spark of Innovation
A Breath of Relief: How Trump's Drug Tariffs Spare India's Generic Pharma Giants

A Breath of Relief: How Trump's Drug Tariffs Spare India's Generic Pharma Giants
Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule
Bristol Myers Squibb Shakes Up Psoriasis Market with Massive Discount for Sotyktu

Bristol Myers Squibb Shakes Up Psoriasis Market with Massive Discount for Sotyktu
The Dawn of a New Era: Keytruda's Patent Cliff and the Future of Cancer Care

The Dawn of a New Era: Keytruda's Patent Cliff and the Future of Cancer Care
Guggenheim Casts a 'Neutral' Eye on Immunocore's Future as Kimmtrak's Path Unfolds

Guggenheim Casts a 'Neutral' Eye on Immunocore's Future as Kimmtrak's Path Unfolds
The UK's Bitter Rift with Big Pharma: A Deep Dive into Disputed Prescriptions

The UK's Bitter Rift with Big Pharma: A Deep Dive into Disputed Prescriptions
Regulatory Heat on AstraZeneca: NPPA Demands Answers on Alleged Drug Overpricing

Regulatory Heat on AstraZeneca: NPPA Demands Answers on Alleged Drug Overpricing
Legal Setback: Eli Lilly's Appeal Fails, $1.8 Billion Medicaid Fraud Award Upheld

Legal Setback: Eli Lilly's Appeal Fails, $1.8 Billion Medicaid Fraud Award Upheld
The Cost-Benefit Revolution: GLP-1 Drugs Deemed Value-Packed, But Price Tags Loom Large

The Cost-Benefit Revolution: GLP-1 Drugs Deemed Value-Packed, But Price Tags Loom Large
A New Era in Health: WHO Adds Mounjaro and Ozempic to Essential Medicines List

A New Era in Health: WHO Adds Mounjaro and Ozempic to Essential Medicines List
Trump's Bold Plan to Slash Drug Costs with Tariffs: A Risky Bet for American Consumers?

Trump's Bold Plan to Slash Drug Costs with Tariffs: A Risky Bet for American Consumers?
The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?

The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?
Global Health Injustice: Poorer Nations Bear Heavier Burden for Essential Drugs

Global Health Injustice: Poorer Nations Bear Heavier Burden for Essential Drugs
Load more..